Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 10 of 84 Projects
Project # Contact PI Funding Organization Fiscal Year
MIB-626 For Treatment of Mild Dementia Patients
ADDF-43 Livingston, David Alzheimer's Drug Discovery Foundation 2021
Testing low-dose efavirenz treatment for Alzheimer’s disease: a phase 1b dosing, target-engagement and exploratory biomarker study.
ADDF-48 SCHELTENS, PHILIP Alzheimer's Drug Discovery Foundation 2021
Depression treatment and Aβ dynamics: A study of Alzheimer's disease risk
1R01AG070821-01A1 POMARA, NUNZIO NIA 2021
A Proof of Concept Trial of a Sirtuin-NAD+ Activator in Alzheimer's Disease
1R01AG071074-01A1 BHASIN, SHALENDER NIA 2021
A Phase 1b Multiple Ascending Dose Study of the Safety and Tolerability of BMS-984923 in Alzheimer's Disease
1R01AG073177-01 MECCA, ADAM PETER NIA 2021
Phase 1 Clinical Trial of CMS121, a Novel Therapeutic Candidate for Alzheimer's Disease
1R01AG074447-01 RASCHKE, WILLIAM C NIA 2021
Long-Term Nicotine Treatment of Mild Cognitive Impairment - Bridge Funding
3R01AG047992-06S2 NEWHOUSE, PAUL A. NIA 2021
Evaluation of Brain and Cognitive Changes in Older Adults with MCI Taking Lithium to Prevent Alzheimer Type Dementia
5R01AG055389-05 GILDENGERS, ARIEL GERARD NIA 2021
Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial
5R01AG063826-02 BRINTON, ROBERTA EILEEN NIA 2021
Long-term therapeutic effects of synthetic bryostatin-1 in advanced AD without memantine
5R44AG066366-02 SUN, MIAO-KUN NIA 2021